{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:52:29Z","timestamp":1792101149166,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clindermatol.2020.06.008","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:40:48Z","timestamp":1593218448000},"page":"702-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Adela R.","family":"Cardones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.06.008_bb0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5414\/ALX01508E","article-title":"Epidemiology of cutaneous adverse drug reactions","volume":"1","author":"Mockenhaupt","year":"2017","journal-title":"Allergol Select"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.arcmed.2006.03.010","article-title":"Epidemiology of adverse cutaneous drug reactions: a prospective study in hospitalized patients","volume":"37","author":"Hernandez-Salazar","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0015","first-page":"36","article-title":"Mild cutaneous reactions to drugs","volume":"90","author":"Crisafulli","year":"2019","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cup.12427","article-title":"Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features","volume":"42","author":"Lehman","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaad.2010.07.042","article-title":"Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions","volume":"65","author":"Byun","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1346-8138.2010.01196.x","article-title":"Pharmacogenetics of cutaneous adverse drug reactions","volume":"38","author":"Aihara","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0050","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0055","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction: results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4168\/aair.2014.6.3.216","article-title":"Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy, Asthma Immunol Res"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0070","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.amjmed.2011.10.027","article-title":"Human herpesvirus 6 reactivation in drug-induced hypersensitivity syndrome and DRESS validation score","volume":"125","author":"Ushigome","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyriere","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0080","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pds.4774","article-title":"Variation of clinical manifestations according to culprit drugs in DRESS syndrome","volume":"28","author":"Sim","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0085","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2019.02.002","article-title":"Vancomycin-associated drug-induced hypersensitivity syndrome","volume":"81","author":"Madigan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0100","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jdv.13212","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases","volume":"29","author":"Skowron","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0110","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/bjd.13162","article-title":"The serum level of HMGB1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"171","author":"Fujita","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4168\/aair.2019.11.2.241","article-title":"Severe cutaneous adverse reactions in Korean pediatric patients: a study from the Korea SCAR Registry","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy, Asthma Immunol Res"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0120","first-page":"66","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in children","volume":"90","author":"Mori","year":"2019","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0140","doi-asserted-by":"crossref","unstructured":"Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010;2:46ra62.","DOI":"10.1126\/scitranslmed.3001116"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0145","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","article-title":"Therapeutic management of DRESS: a retrospective study of 38 cases","volume":"72","author":"Funck-Brentano","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jdv.12419","article-title":"Recurrence of drug-induced reactions in DRESS patients","volume":"29","author":"Picard","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0160","first-page":"139","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management","volume":"16","author":"Shiohara","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0165","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0170","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/ced.12246","article-title":"Increased ratio of FoxP3+ regulatory T cells\/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms","volume":"39","author":"Morito","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0175","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0180","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/cea.13252","article-title":"Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions","volume":"48","author":"Ushigome","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0185","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaad.2015.11.031","article-title":"Plasmacytoid dendritic cells (pDCs) and regulatory T (Treg) cells may be the key to viral reactivation in drug-induced hypersensitivity syndrome (DIHS)","volume":"74","author":"Chen","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0190","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jid.2018.10.048","article-title":"Increased type 2 innate lymphoid cells in patients with drug reaction with eosinophilia and systemic symptoms syndrome","volume":"139","author":"Tsai","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0195","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","article-title":"Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity","volume":"105","author":"Shear","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0205","doi-asserted-by":"crossref","first-page":"h4848","DOI":"10.1136\/bmj.h4848","article-title":"Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study","volume":"351","author":"Ko","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2340\/00015555-0528","article-title":"HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions","volume":"88","author":"Kano","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000102045","article-title":"Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?","volume":"215","author":"Dainichi","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0220","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0230","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/bcp.14025","article-title":"High and variable population prevalence of HLA-B*56:02 in Indigenous Australians and relation to phenytoin-associated DRESS","volume":"85","author":"Somogyi","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1346-8138.2008.00548.x","article-title":"Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients","volume":"35","author":"Kashiwagi","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"issue":"709","key":"10.1016\/j.clindermatol.2020.06.008_bb0245","first-page":"e701","article-title":"DRESS syndrome: part II. Management and therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0250","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0255","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/all.12410","article-title":"The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome","volume":"69","author":"Ishida","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0260","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mcna.2010.03.004","article-title":"Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome","volume":"94","author":"Kano","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0265","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10194","article-title":"Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome","volume":"51","author":"Fujino","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0270","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2169\/internalmedicine.55.6035","article-title":"Autoimmune limbic encephalitis and syndrome of inappropriate antidiuretic hormone secretion associated with lamotrigine-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"55","author":"Ozisik","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0275","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/TP.0000000000001655","article-title":"Acute liver failure\/injury related to drug reaction with eosinophilia and systemic symptoms: outcomes and prognostic factors","volume":"101","author":"Ichai","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.11622\/smedj.2018016","article-title":"Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms","volume":"59","author":"Wong","year":"2018","journal-title":"Singap Med J"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0285","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0290","doi-asserted-by":"crossref","first-page":"978","DOI":"10.12659\/AJCR.909569","article-title":"Myocarditis associated with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and review of the literature","volume":"19","author":"Morikawa","year":"2018","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0295","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0300","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0305","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2007.07784.x","article-title":"Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome","volume":"156","author":"Kano","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0310","doi-asserted-by":"crossref","first-page":"CS57","DOI":"10.12659\/MSM.883198","article-title":"Treatment of DIHS\/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir\u2014a hypothesis","volume":"18","author":"Moling","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0315","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/pde.13408","article-title":"Use of antiviral medications in drug reaction with eosinophilia and systemic symptoms (DRESS): a case of infantile DRESS","volume":"35","author":"Chow","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0330","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0335","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000448284","article-title":"Evaluation of lymphocyte transformation test results in patients with delayed hypersensitivity reactions following the use of anticonvulsant drugs","volume":"170","author":"Karami","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0340","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1468-3083.2012.04547.x","article-title":"Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids","volume":"27","author":"Uhara","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1684\/ejd.2011.1300","article-title":"Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone","volume":"21","author":"Natkunarajah","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0350","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamadermatol.2013.1949","article-title":"A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins","volume":"149","author":"Singer","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0355","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.jaad.2011.06.038","article-title":"Successful treatment of lamotrigine-associated drug hypersensitivity syndrome with intravenous IgG","volume":"66","author":"Comfere","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0360","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaip.2017.10.016","article-title":"Successful intravenous immunoglobulin treatment in pediatric severe DRESS syndrome","volume":"6","author":"Marcus","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0365","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","article-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","volume":"148","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0370","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2009.05.046","article-title":"Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis","volume":"62","author":"Shaughnessy","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0375","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaip.2019.06.020","article-title":"Severe acute hepatitis in drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome resolved following cyclosporine","volume":"8","author":"Ton","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0380","first-page":"41","article-title":"Cyclosporine treatment of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report and brief review of the literature","volume":"2018","author":"Kuschel","year":"2018","journal-title":"Pract Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.008_bb0385","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","article-title":"Cyclosporine treatment of drug-induced hypersensitivity syndrome","volume":"152","author":"Kirchhof","year":"2016","journal-title":"JAMA Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:03Z","timestamp":1760033883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0738081X20301413"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.008","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}